Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 309 of 6351
-
Can a new pill reach brain tumors and halt their growth?
Disease control Not yet recruitingThis is an open-label, single arm, non-randomized, Phase 0 and expansion Phase 1 study of NST-628 in adult patients with recurrent Grade 4 glioma with high phosphorylated extracellular signal-regulated kinase (pERK) expression who are scheduled for surgical resection. This study …
Early phase 1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
A new procedure may offer relief for Cirrhosis-Related fluid buildup
Disease control Not yet recruitingThe purpose of this study is to learn whether a procedure called Proximal Splenic Artery Embolization (PSAE) can lower the need for repeat fluid drainage in adults with cirrhosis and a buildup of fluid in the abdomen (ascites) that is no longer controlled by water pills and diet.…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a birch bark gel soothe blistering skin disease?
Symptom relief Not yet recruitingThis pilot study will look at whether the topical Birch Triterpenes (Filsuvez) gel is safe and helpful for adults and children 6 months of age and older who have moderate to severe epidermolysis bullosa simplex (EBS). The study will examine whether the gel can reduce the number o…
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Could a calf workout be the key to healing stubborn leg ulcers?
Symptom relief Not yet recruitinginvestigates the comparative effectiveness of two interventions aimed at promoting the healing of venous leg ulcers-a common chronic condition characterized by impaired venous return and poor wound healing in the lower extremities. The research explores whether structured and sup…
Sponsor: MTI University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a daily pill tame hepatitis d?
Disease control Not yet recruitingThis study is designed to assess safety, pharmacokinetics, and efficacy ABI-6250 in participants with Chronic Hepatitis D Virus Infection.
Phase 2 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new acid blocker match the standard for stopping GI bleeding?
Disease control Not yet recruitingAcute non-variceal upper gastrointestinal bleeding (ANVUGIB) is a common medical emergency requiring hospitalization. The cornerstone of ANVUGIB management is effective gastric acid suppression. Potassium-competitive acid blockers (P-CABs) represent a novel class of gastric acid …
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a smartphone app tame chronic pain after spinal injury?
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the efficacy of a 6-week app-guided MM intervention compared to a 6-week app-guided health education AC condition on pain intensity, pain interference, depression, and anxiety.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
AI app aims to boost wellbeing across eight life dimensions
Symptom relief Not yet recruitingThis study will evaluate the effect of an artificial intelligence-supported digital wellbeing platform, Wellbeing All-In-One (WAIO), on multidimensional wellbeing in adults living in Argentina. The study includes an initial phase to evaluate and refine a culturally adapted wellb…
Sponsor: Instituto Tecnológico de Buenos Aires • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New drug TAX2 targets Hard-to-Treat cancers in first human trial
Disease control Not yet recruitingThe purpose of this clinical trial is to investigate the treatment for adult patients suffering from advanced or metastatic solid tumours and has 2 parts to the study: the Phase 1 where ascending doses of the experimental study drug, TAX2, will be tested and the Phase 2a where al…
Phase 1/2 • Sponsor: Apmonia Therapeutics • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
A urine test strip that could transform kidney diet care?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to evaluate whether the integration of URIKI, a connected urine test strip and in vitro diagnostic medical device, can improve the nutritional management of patients with stage 4 or 5 chronic kidney disease (CKD) living at home. The primary purp…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can a new gel calm psoriasis Flare-Ups?
Disease control Not yet recruitingThis trial is a Phase IIa clinical trial. Around 65 subjects will be enrolled into this study to primarily assess the treatment efficacy of 5% GM-XANTHO in patients with psoriasis, as well as the safety and tolerability of 5% GM-XANTHO. Two third of the total subjects will be giv…
Phase 2 • Sponsor: Xantho Biotechnology Co., LTD • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can brain stimulation tame ataxia?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and feasibility of deep brain stimulation (DBS) in the deep cerebellar nuclei (DCN) in patients with Spinocerebellar Ataxia (SCA) types 1 and 3. Primary Objective: The incidence and nature of treatment-related adverse events ac…
Sponsor: Gordon H. Baltuch • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
A simple drink may help seniors rebuild strength after illness
Disease control Not yet recruitingThe study aims to determine the effects of Oral Nutritional Supplement (ONS) added to usual care on body weight compared with usual care alone in community-dwelling adults aged 55 years and older who are at risk of malnutrition and have low muscle strength following acute care. …
Sponsor: Abbott Nutrition • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Hope for rett syndrome: new drug trial targets behavior and communication
Symptom relief Recruiting nowPrimary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and wom…
Phase 3 • Sponsor: Biomed Industries, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New pill aims to tame stubborn high blood pressure
Disease control Not yet recruitingThis is a Phase IIIb, multicentre, randomised, double-blind, placebo-controlled, parallel group study to evaluate the effect of baxdrostat 2mg versus placebo, administered QD orally, on the reduction of ambulatory 24-hour average SBP in participants with uHTN. Consenting partici…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Single infusion may prevent chronic headaches after concussion
Disease control Not yet recruitingMost individuals with mild traumatic brain injury (mTBI) experience post-traumatic headaches (PTH). Of PTH, 50% present with a migraine phenotype which is the most disabling type of PTH. Patients with migraine-PTH are at greater risk of persistent symptoms whereby the acute PTH (…
Phase 3 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Implanted nerve stimulator aims to restore walking after spinal injury
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, feasibility, and preliminary effectiveness of the ReWire system, which delivers vagus nerve stimulation (VNS) paired with lower limb rehabilitation to improve gait in individuals with mobility impairments resulting from chronic…
Sponsor: The University of Texas at Dallas • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could your own blood cells ease knee arthritis pain?
Disease control Not yet recruitingThe goal of this Phase II/III, double-blinded, multicenter clinical trial is to assess the clinical efficacy of autologous peripheral blood mononuclear cells (PBMCs) in the management of knee osteoarthritis (KOA). The main questions it aims to answer are: 1. To determine the saf…
Phase 2/3 • Sponsor: DuoGenic StemCells Corporation (DGSC) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Brain zaps boost therapy for PTSD in troops with head injuries
Symptom relief Not yet recruitingIn this study, the investigators are evaluating whether transcranial direct current stimulation (tDCS), a brain stimulation technique, can be combined with Written Exposure Therapy (WET), a standard talk therapy for posttraumatic stress disorder (PTSD) to improve treatment respon…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can a new stent graft reinforce a weakened aorta and prevent rupture?
Disease control Recruiting nowThe objective of this clinical investigational study is to evaluate the safety and efficacy of the Ankura™ II AAA, AE Stent Graft System and the large-size Ankura™ II IE Stent Graft System (i.e., IE stent grafts with distal diameters of 24, 26, and 28 mm) for endovascular treatme…
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC